"Neumora’s Alzheimer’s disease agitation drug shows early success in Phase Ib trial" was originally created and published by ...

Alzheimer’s disease affects millions worldwide—but confirming a diagnosis is far from simple. Doctors currently rely on ...

Summary: Researchers have created a new experimental model that reveals how changing a key Alzheimer’s risk gene can shift ...

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer’s disease. A new JCI Insight study ...

A new method of reversing Alzheimer's shows promise in an animal study, as researchers at University Hospitals restore brain ...

One of the biggest challenges in treating Alzheimer's disease (AD) is how heterogeneous it is in terms of speed of decline ...

A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear.

The Alzheimer’s Association has earned Joint Accreditation status to provide interprofessional continuing education from Joint Accreditation for Interprofessional Continuing Education, the ...

The program allows caregivers to voluntarily register their loved ones to wear a small wrist or ankle transmitter that would help a response team get them home safely.

A finger-prick blood test that can be mailed to a lab may offer a simpler way to detect the brain changes linked to Alzheimer ...

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...

Most often, caregivers are “told” what they should or could be doing in the care of their loved ones with Alzheimer’s disease ...